COMPARISON OF THROMBOLYTIC, FIBRINOLYTIC, AND FIBRINOGENOLYTIC PROPERTIES OF TISSUE PLASMINOGEN-ACTIVATOR, STREPTOKINASE, SINGLE-CHAIN UROKINASE, HIGH MOLECULAR-WEIGHT AND LOW-MOLECULAR WEIGHT UROKINASE IN HUMAN-PLASMA INVITRO

被引：7
|
作者：
SAMAMA, M
NGUYEN, G
DESNOYERS, P
LOURENCO, DM
FRETAULT, J
HORELLOU, MH
CONARD, J
SZWARCER, E
VERDY, E
VAHANIAN, A
机构：
[1] HOTEL DIEU, ISOTOPES LAB, F-75181 PARIS 04, FRANCE
[2] HOP TENON, HEMATOL LAB, F-75970 PARIS 20, FRANCE
[3] HOP TENON, SERV CARDIOL, F-75970 PARIS 20, FRANCE
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1988年 / 2卷 / 06期
关键词：
D O I：
10.1111/j.1472-8206.1988.tb00652.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：509 / 523
页数：15
相关论文
共 50 条
  • [31] POTENTIATION BY HEPARIN FRAGMENTS OF THROMBOLYSIS INDUCED WITH HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR OR HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    STASSEN, JM
    JUHANVAGUE, I
    ALESSI, MC
    DECOCK, F
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 947 - 950
  • [32] ABSENCE OF SYNERGISM BETWEEN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA), SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) AND UROKINASE ON CLOT LYSIS IN A PLASMA MILIEU INVITRO
    COLLEN, D
    DECOCK, F
    DEMARSIN, E
    LIJNEN, HR
    STUMP, DC
    THROMBOSIS AND HAEMOSTASIS, 1986, 56 (01) : 35 - 39
  • [33] INTRAVENOUS THROMBOLYTIC THERAPY WITH A COMBINATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BODE, C
    SCHULER, G
    NORDT, T
    SCHONERMARK, S
    BAUMANN, H
    RICHARDT, G
    DIETZ, R
    GUREWICH, V
    KUBLER, W
    CIRCULATION, 1990, 81 (03) : 907 - 913
  • [34] EFFECT OF RECOMBINANT-TISSUE PLASMINOGEN-ACTIVATOR, LOW-MOLECULAR-WEIGHT UROKINASE AND UNFRACTIONATED HEPARIN ON PLATELET-AGGREGATION
    PAOLINI, R
    CASONATO, A
    BOERI, G
    LUZZATTO, G
    GIROLAMI, A
    SASAHARA, AA
    CELLA, G
    JOURNAL OF MEDICINE, 1993, 24 (2-3) : 113 - 130
  • [35] COMPARATIVE-STUDY OF THROMBOLYSIS BY HIGH AND LOW-MOLECULAR WEIGHT UROKINASE IN AN INVITRO PERFUSION SYSTEM
    GREENWALD, SR
    CHANDLER, AB
    THROMBOSIS RESEARCH, 1983, 31 (06) : 799 - 806
  • [36] EVIDENCE FOR SYNERGISM BETWEEN TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND SINGLE CHAIN UROKINASE ON INVITRO PLASMA CLOT LYSIS
    RAPPAPORT, RS
    BLUME, MR
    VOGEL, RL
    LEVNER, MH
    HUNG, PP
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 30 - 30
  • [37] BIOCHEMICAL AND BIOLOGICAL CHARACTERIZATION OF A NOVEL LOW-MOLECULAR-WEIGHT FORM OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA)
    STUMP, DC
    LIJNEN, HR
    COLLEN, D
    CIRCULATION, 1986, 74 (04) : 247 - 247
  • [38] CHARACTERIZATION OF RECOMBINANT HUMAN SINGLE-CHAIN LOW-MOLECULAR-WEIGHT UROKINASE (RE-SC-LUK)
    GUNZLER, WA
    WOLF, B
    FLOHE, L
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 216 - 216
  • [39] THROMBOLYTIC PROPERTIES OF TISSUE PLASMINOGEN-ACTIVATOR (T-PA) AND SINGLE CHAIN UROKINASE PLASMINOGEN-ACTIVATOR (SCU-PA) INVITRO - ABSENCE OF SYNERGY AS DEMONSTRATED BY 2 QUANTITATIVE ANALYTICAL METHODS
    NGUYEN, G
    FRETAULT, J
    SAMAMA, M
    COURSAGET, J
    FIBRINOLYSIS, 1989, 3 (01) : 23 - 26
  • [40] SELECTIVE FIBRINOLYTIC-ACTIVITY OF RECOMBINANT NONGLYCOSYLATED HUMAN PROUROKINASE (SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR) FROM BACTERIA
    HANBUCKEN, FW
    SCHNEIDER, J
    GUNZLER, WA
    FRIDERICHS, E
    GIERTZ, H
    FLOHE, L
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (08): : 993 - 997
12345